Current News

Contact | Print version | PDF version | Send article | RSS feed

Devgen receives IWT grant to support its obesity drug discovery program

27 Feb 2007 - Devgen has been awarded a 0.9 million Euro technology grant from the Flanders government through IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders) to develop new targets and therapeutic solutions for the treatment of obesity.
 
In its obesity program, Devgen takes a multidisciplinary approach to validate a novel class of kinase targets. According to the company, IWT's support for this program is very important for Devgen, not only from a funding perspective, but it is an endorsement of the innovative approach and validation opportunities of this program. The funding covers a period of 16 months.